Dr. King Li, dean of the Carle Illinois College of Medicine, has been admitted into the AIMBE College of Fellows, comprised of the top two percent of medical and biological engineers.
A Carle Illinois College of Medicine Executive Associate Dean, Dr. Rashid Bashir, collaboration with Mayo has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue sample while preserving the spatial information across the tissue.
Illinois researchers developed nanoparticles that can target cancer stem cells (yellow), the rare cells within a tumor (blue) that can cause cancer to recur or spread.
Carle Illinois researchers developed nanoparticles that can target cancer stem cells, the rare cells within a tumor that can cause cancer to recur or spread.
Illinois researchers are testing the safety of a new cancer drug in a clinical trial for humans with late-stage brain cancer.
Meet Judith L. Rowen, M.D., our first permanent associate dean for academic affairs.
Professor Dipanjan Pan and Carle ophthalmologist Leanne Labriola, DO, have developed a device called OcuCheck, which recently resulted in Phase II funding from the National Science Foundation.
Dr. King Li, inaugural dean of the Carle Illinois College of Medicine, has a message for prospective students interested in joining our first class of future physician-innovators. Watch the video.
We’ve achieved preliminary accreditation from the LCME and are now actively recruiting our first class with full four-year scholarships.